Blood Purification in Patients with Sepsis Associated with Acute Kidney Injury: A Narrative Review.
Jun KameiMasafumi KanamotoYutaka IgarashiKodai SuzukiKensuke FujitaTsukasa KuwanaTakayuki OguraKatsunori MochizukiYuki BanshotaniHiroyasu IshikuraYoshihiko Nakamuranull J-Stad Japan Sepsis Treatment And Diagnosis Study GroupPublished in: Journal of clinical medicine (2023)
Sepsis leads to organ dysfunction. Acute kidney injury, a common type of organ dysfunction, is associated with a high mortality rate in patients with sepsis. Kidney replacement therapy can correct the metabolic, electrolyte, and fluid imbalances caused by acute kidney injury. While this therapy can improve outcomes, evidence of its beneficial effects is lacking. Herein, we review the indications for blood purification therapy, including kidney replacement therapy, and the current knowledge regarding acute kidney injury in terms of renal and non-renal indications. While renal indications have been well-documented, indications for blood purification therapy in sepsis (non-renal indications) remain controversial. Excessive inflammation is an important factor in the development of sepsis; blood purification therapy has been shown to reduce inflammatory mediators and improve hemodynamic instability. Given the pathophysiology of sepsis, blood purification therapy may decrease mortality rates in these patients. Further trials are needed in order to establish the effectiveness of blood purification therapy for sepsis.
Keyphrases
- acute kidney injury
- replacement therapy
- cardiac surgery
- septic shock
- intensive care unit
- oxidative stress
- randomized controlled trial
- cardiovascular disease
- cardiovascular events
- metabolic syndrome
- smoking cessation
- stem cells
- end stage renal disease
- recombinant human
- physical activity
- cell therapy
- risk factors
- prognostic factors
- patient reported outcomes
- weight gain